Compare · CVR vs TMO
CVR vs TMO
Side-by-side comparison of Chicago Rivet & Machine Co. (CVR) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CVR and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $225.41B, about 8973.4x CVR ($25.1M).
- Over the past year, CVR is up 5.9% and TMO is up 11.5% - TMO leads by 5.6 points.
- TMO has been more active in the news (6 items in the past 4 weeks vs 1 for CVR).
- TMO has more recent analyst coverage (25 ratings vs 0 for CVR).
- Company
- Chicago Rivet & Machine Co.
- Thermo Fisher Scientific Inc
- Price
- $10.99+4.07%
- $469.57+0.63%
- Market cap
- $25.1M
- $225.41B
- 1M return
- -22.93%
- -4.31%
- 1Y return
- +5.88%
- +11.45%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- 1930
- News (4w)
- 1
- 6
- Recent ratings
- 0
- 25
Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co. operates in the fastener industry in North America. It operates in two segments, Fasteners and Assembly Equipment. The Fastener segment manufactures and sells rivets, cold-formed fasteners and parts, and screw machine products. The Assembly Equipment segment manufactures automatic rivet setting machines and assembly equipment, as well as parts and tools for related machines. The company sells its products to automobile and automotive component manufacturers through independent sales representatives. Chicago Rivet & Machine Co. was founded in 1920 and is headquartered in Naperville, Illinois.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest CVR
- Chicago Rivet & Machine Co. Announces Year-End Results of Operations
- Chicago Rivet & Machine Co. Announces Year-End Results of Operations
- SEC Form 10-K filed by Chicago Rivet & Machine Co.
- /C O R R E C T I O N -- Chicago Rivet & Machine Co./
- CHICAGO RIVET & MACHINE CO. DECLARES DIVIDEND
- Large owner Morrissey John A bought $36,431 worth of shares (2,537 units at $14.36), increasing direct ownership by 3% to 100,000 units (SEC Form 4)
- New insider Morrissey John A claimed ownership of 97,463 shares (SEC Form 3)
- SEC Form SCHEDULE 13D filed by Chicago Rivet & Machine Co.
- CHICAGO RIVET & MACHINE CO. DECLARES DIVIDEND
- Chicago Rivet & Machine Co. Announces Third Quarter Results of Operations
Latest TMO
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026
- SEC Form 4 filed by Sperling Scott M
- SEC Form 4 filed by Keith R. Alexandra
- SEC Form 4 filed by Lynch Karen S